Aug 5, 2026 08:00AM
Aug 3, 2026 04:01PM
Jul 27, 2026 04:01PM
Jul 15, 2026 01:29PM
Jul 14, 2026 11:15AM
Jul 14, 2026 11:15AM
Jul 14, 2026 09:15AM Biogen Phase 2 data shows diranersen slows Alzheimer's decline
Jul 14, 2026 09:15AM
Jul 13, 2026 05:37PM
Jul 13, 2026 05:36PM
Jul 13, 2026 07:30AM
Jul 13, 2026 07:30AM
Jul 13, 2026 05:43AM
Jul 12, 2026 11:15AM LEQEMBI® Subcutaneous Autoinjector Clinical Data Supports Similar Efficacy and Safety to IV Formulation in Early Alzheimer's Disease Presented at the Alzheimer's Association International Conference�
Jun 30, 2026 08:01AM
Jun 30, 2026 08:00AM
Jun 29, 2026 06:59AM
Jun 29, 2026 06:59AM
Jun 22, 2026 09:05AM
Jun 22, 2026 08:30AM
Jun 4, 2026 07:30AM Biogen's salanersen gets FDA breakthrough therapy designation for SMA
Jun 4, 2026 07:30AM
May 28, 2026 04:01PM
May 21, 2026 06:00PM
May 21, 2026 06:00PM
May 14, 2026 07:16AM
May 14, 2026 06:59AM
May 14, 2026 06:59AM Topline Results from Phase 2 CELIA Study of Diranersen (BIIB080): First Study to Show Reduction in Tau Pathology and Cognitive Benefit in Patients with Early Alzheimer’s Disease
May 8, 2026 02:30AM
May 8, 2026 02:30AM
May 7, 2026 04:01PM
Apr 30, 2026 04:01PM
Apr 8, 2026 04:01PM
Apr 7, 2026 04:01PM
Apr 7, 2026 04:01PM Stoke Therapeutics Appoints Clare Kahn, Ph.D., to its Board of Directors
Mar 31, 2026 06:59AM
Mar 31, 2026 06:59AM
Mar 30, 2026 09:24AM
Mar 30, 2026 07:30AM
Mar 30, 2026 07:30AM
Mar 28, 2026 03:00PM
Mar 28, 2026 03:00PM Biogen Announces Second Positive Phase 2 Litifilimab Trial in Cutaneous Lupus Erythematosus at 2026 American Academy of Dermatology Annual Meeting, Showing a Significant Reduction in Skin Disease Acti
Mar 20, 2026 12:13PM
Mar 20, 2026 12:05PM
Mar 19, 2026 07:30AM
Mar 19, 2026 07:30AM
Mar 5, 2026 07:30AM
Mar 4, 2026 05:05PM
Feb 24, 2026 04:01PM Stoke Therapeutics to Present at the TD Cowen 46th Annual Health Care Conference
Feb 11, 2026 05:00PM

327,796 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All